These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2327767)

  • 21. Comparison of amoxicillin and clavulanic acid (augmentin) for the treatment of nonbullous impetigo.
    Dagan R; Bar-David Y
    Am J Dis Child; 1989 Aug; 143(8):916-8. PubMed ID: 2667333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of amoxicillin and clavulanic acid in infected animals and efficacy against experimental infections.
    Boon RJ; Beale AS; Comber KR; Pierce CV; Sutherland R
    Antimicrob Agents Chemother; 1982 Sep; 22(3):369-75. PubMed ID: 7137980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clavulanic acid-shielded amoxicillin in the treatment of acute and chronic infective diseases of the pulmonary system].
    Micillo E; Dericoloso A; Tranchese D; Cione P
    Arch Monaldi Mal Torace; 1987; 42(6):535-49. PubMed ID: 3334116
    [No Abstract]   [Full Text] [Related]  

  • 24. [Augmentin--current and prospective therapeutic indications].
    Mihălţan F
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1988; 37(3):203-10. PubMed ID: 2855664
    [No Abstract]   [Full Text] [Related]  

  • 25. [Usefulness of an amoxicillin/clavulanic-acid combination in respiratory tract infection: bacterial resistance and antibiotic therapy].
    Caramia M; Taddei G; Nobilini A
    Minerva Pediatr; 1990; 42(1-2):29-34. PubMed ID: 2186263
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Amoxicillin/clavulanate therapy of respiratory tract infections: a microbiologic perspective.
    Cunha BA
    Clin Ther; 1992; 14(3):418-25. PubMed ID: 1638583
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cefixime versus amoxicillin/clavulanic acid in lower respiratory tract infections.
    Beumer HM
    Int J Clin Pharmacol Ther Toxicol; 1989 Jan; 27(1):30-3. PubMed ID: 2663735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Roxithromycin versus amoxicillin-clavulanic acid in the treatment of respiratory tract infections.
    Lousbergh D; Jochems G; Everaert L; Puttemans M
    Diagn Microbiol Infect Dis; 1992; 15(4 Suppl):91S-95S. PubMed ID: 1617931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amoxicillin-potassium clavulanate: a novel beta-lactamase inhibitor.
    Smith BR; LeFrock JL
    Drug Intell Clin Pharm; 1985 Jun; 19(6):415-20. PubMed ID: 3891282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Bactericide activity of cefadroxil comparated with amoxicillin-clavulanic acid, cefaclor and josamycin].
    Etesse-Carsenti H; Caillon J; Mondain V; Durant J; Bernard E; Dellamonica P; Drugeon HB
    Pathol Biol (Paris); 1991 Sep; 39(7):658-67. PubMed ID: 1758716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ofloxacin in the treatment of lower respiratory tract infections: report of a prospective, comparative trial.
    Khajotia RR; Vetter N; Harazin H
    Clin Ther; 1991; 13(4):460-6. PubMed ID: 1933997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Laboratory and clinical studies of BRL 25000 (clavulanic acid-amoxicillin) granules in the pediatric field].
    Nishimura T; Tabuki K; Takashima T; Takagi M
    Jpn J Antibiot; 1985 Feb; 38(2):431-40. PubMed ID: 4009952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vitro study to compare sensitivity of amoxicillin+clavulanic acid and cefpodoxime+clavulanic acid among beta-lactamase positive clinical isolates of gram-positive and gram-negative pathogens.
    Pal RB; Pal P; Jain S; Kulkarni KP
    J Indian Med Assoc; 2008 Aug; 106(8):545-8. PubMed ID: 18975519
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sinus tissue pharmacokinetics after oral administration of amoxicillin/clavulanic acid.
    Dinis PB; Monteiro MC; Martins ML; Silva N; Gomes A
    Laryngoscope; 2000 Jun; 110(6):1050-5. PubMed ID: 10852529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amoxicillin and potassium clavulanate: an antibiotic combination. Mechanism of action, pharmacokinetics, antimicrobial spectrum, clinical efficacy and adverse effects.
    Weber DJ; Tolkoff-Rubin NE; Rubin RH
    Pharmacotherapy; 1984; 4(3):122-36. PubMed ID: 6739312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Comparison of amoxicillin and amoxiclav in the therapy of respiratory infections].
    Music E; Kumelj M; Prlja D; Paulin A; Potokar T
    Plucne Bolesti; 1989; 41(3-4):187-92. PubMed ID: 2636405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics and tissue distribution of amoxicillin plus clavulanic acid after oral administration in man.
    Fraschini F; Scaglione F; Falchi M; Dugnani S; Mezzetti M; Cicchetti F; Alfano G; Pintucci GP
    J Chemother; 1990 Jun; 2(3):171-7. PubMed ID: 2199627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Sentinel Project: an update on the prevalence of antimicrobial resistance in community-acquired respiratory Streptococcus pneumoniae and Haemophilus spp. in Italy.
    Marchese A; Ardito F; Fadda G; Fontana R; Lo Cascio G; Nicoletti G; Speciale AM; Schito GC
    Int J Antimicrob Agents; 2005 Jul; 26(1):8-12. PubMed ID: 15967638
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bactericidal effect of cefadroxil, amoxicillin alone or in combination with clavulanic acid in sera of healthy volunteers].
    Etesse-Carsenti H; Garraffo R; Bernard E; de Salvador F; Pradier C; Durant J; Mondain V; Drugeon HB; Dellamonica P
    Pathol Biol (Paris); 1991 Dec; 39(10):972-7. PubMed ID: 1805138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Experimental evidence for Moraxella-induced penicillin neutralization in pneumococcal pneumonia.
    Hol C; Van Dijke EE; Verduin CM; Verhoef J; van Dijk H
    J Infect Dis; 1994 Dec; 170(6):1613-6. PubMed ID: 7996007
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.